Vireo Growth Inc. (VREOF) stock
VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/30
$9.01+0.01 (+0.11%)
Close on Oct 19, 2026Market cap $443.48MP/E –Yield –
Vireo Growth total assets
Total assets on the balance sheet at the end of each period.
Vireo Growth's total assets was $1.42B at Sep 30, 2026. For fiscal 2025 it was $817.20M, up 193.0% from the year before. The highest annual figure on record is $817.20M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $817.20M | +193.0% |
| FY2024 | Dec 31, 2024 | $278.86M | +52.2% |
| FY2023 | Dec 31, 2023 | $183.26M | +15.1% |
| FY2022 | Dec 31, 2022 | $159.16M | -4.7% |
| FY2021 | Dec 31, 2021 | $166.97M | +62.7% |
| FY2020 | Dec 31, 2020 | $102.63M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.42B | +109.8% |
| Q2 FY2026 | Jun 30, 2026 | $1.27B | +93.2% |
| Q1 FY2026 | Mar 31, 2026 | $928.80M | +235.3% |
| Q4 FY2025 | Dec 31, 2025 | $817.20M | +193.0% |
| Q3 FY2025 | Sep 30, 2025 | $678.92M | +250.2% |
| Q2 FY2025 | Jun 30, 2025 | $659.34M | +238.7% |
| Q1 FY2025 | Mar 31, 2025 | $277.05M | +45.1% |
| Q4 FY2024 | Dec 31, 2024 | $278.86M | +52.2% |
| Q3 FY2024 | Sep 30, 2024 | $193.87M | +12.9% |
| Q2 FY2024 | Jun 30, 2024 | $194.68M | +17.3% |
| Q1 FY2024 | Mar 31, 2024 | $190.88M | +20.3% |
| Q4 FY2023 | Dec 31, 2023 | $183.26M | +15.1% |
| Q3 FY2023 | Sep 30, 2023 | $171.67M | -1.0% |
| Q2 FY2023 | Jun 30, 2023 | $165.95M | -1.7% |
| Q1 FY2023 | Mar 31, 2023 | $158.63M | -1.3% |
| Q4 FY2022 | Dec 31, 2022 | $159.16M | -4.7% |
| Q3 FY2022 | Sep 30, 2022 | $173.32M | +5.6% |
| Q2 FY2022 | Jun 30, 2022 | $168.82M | +49.8% |
| Q1 FY2022 | Mar 31, 2022 | $160.73M | +30.2% |
| Q4 FY2021 | Dec 31, 2021 | $166.97M | +62.7% |
| Q3 FY2021 | Sep 30, 2021 | $164.16M | – |
| Q2 FY2021 | Jun 30, 2021 | $112.68M | – |
| Q1 FY2021 | Mar 31, 2021 | $123.45M | – |
| Q4 FY2020 | Dec 31, 2020 | $102.63M | – |
See a number that looks wrong?